Horizon Pharma (HZNP)

Add to Watchlists Create an Alert
13.98 -0.20  -1.38% NASDAQ Jul 25, 11:56AM BATS Real time Currency in USD
View Full Chart
HZNP Price Chart
View All Events

HZNP Events

Date Type Description
05/09/2014 08:00 EDT Misc Q1 2014 Horizon Pharma Inc Earnings Conference Call
05/09/2014 Earnings Q1 2014 Horizon Pharma Inc Earnings Results. Estimate: 0.04.
03/19/2014 Misc Horizon Pharma to Acquire Vidara Therapeutics International Ltd. And Become Horizon Pharma Plc
03/13/2014 08:00 EDT Misc Q4 2013 Horizon Pharma Earnings Call
03/13/2014 Earnings Q4 2013 Horizon Pharma Earnings Results. Estimate: -0.06.
11/19/2013 08:00 EST Misc Horizon Pharma Conference Call
11/19/2013 Misc Horizon Pharma Announces Agreement to Acquire u.s. Rights to Vimovo(r) and Provides 2014 Guidance
11/08/2013 08:00 EDT Misc Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2013 Financial Results on November 8, 2013
11/08/2013 Earnings Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2013 Financial Results. Estimate: -0.29.
08/09/2013 08:00 EDT Misc Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2013 Financial Results on August 9, 2013
View All Performance Charts

HZNP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Horizon Pharma is up 452.4% over the last year vs S&P 500 Total Return up 19.77%, POZEN up 71.71%, and ImmunoBiotics down 92.14%.

Get Quote for

PDF Report for HZNP

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download HZNP Pro Report PDF
Advertisement

Portfolio Strategies Featuring HZNP

Did Horizon Pharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

HZNP Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Company Website: http://www.horizonpharma.com
  • IR Website: http://ir.horizon-pharma.com/
  • HQ Country: United States
  • HQ State/Province: Illinois
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.

HZNP Excel Add-In Codes

  • Name: =YCI("HZNP","name")
  • Description: =YCI("HZNP","description")
  • Sector: =YCI("HZNP","sector")
  • Industry: =YCI("HZNP","industry")
  • Est. Current Fiscal Year End: =YCI("HZNP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.